CSIMarket



Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

LLY's Revenue Growth by Quarter and Year

Eli Lilly And's Revenue results by quarter and year




LLY Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 7,999.90 7,440.00 6,114.00
III Quarter September - 6,772.80 5,740.60 5,476.60
II Quarter June - 6,740.10 5,499.40 5,636.70
I Quarter March 7,810.00 6,805.60 5,859.80 5,092.20
FY   7,810.00 28,318.40 24,539.80 22,319.50



LLY Revenue first quarter 2022 Y/Y Growth Comment
Eli Lilly And Company achieved in the first quarter 2022, above Company average Revenue increase of 14.76% year on year, to $ 7,810.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Revenue growth. While Eli Lilly And Company' s Revenue growth of 14.76% ranks overall at the positon no. 253 in the first quarter 2022.




LLY Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 7.53 % 21.69 % -14.32 %
III Quarter September - 17.98 % 4.82 % -9.66 %
II Quarter June - 22.56 % -2.44 % -11.31 %
I Quarter March 14.76 % 16.14 % 15.07 % -10.66 %
FY   - 15.4 % 9.95 % -11.62 %

Financial Statements
Eli Lilly And's first quarter 2022 Revenue $ 7,810.00 millions LLY's Income Statement
Eli Lilly And's first quarter 2021 Revenue $ 6,805.60 millions Quarterly LLY's Income Statement
New: More LLY's historic Revenue Growth >>


LLY Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 18.12 % 29.6 % 11.64 %
III Quarter September - 0.49 % 4.39 % -2.84 %
II Quarter June - -0.96 % -6.15 % 10.69 %
I Quarter March -2.37 % -8.53 % -4.16 % -28.64 %
FY (Year on Year)   - 15.4 % 9.95 % -11.62 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #14
Overall #253

Revenue Y/Y Growth Statistics
High Average Low
11.83 % 1.34 % -4.48 %
(Sep. 30, 2015)   (June 30. 2014)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #14
Overall #253
Revenue Y/Y Growth Statistics
High Average Low
11.83 % 1.34 % -4.48 %
(Sep. 30, 2015)   (June 30. 2014)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Eli Lilly And's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
29.6 % 1.5 % -28.64 %
 


LLY's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Eli Lilly And Company reported fall in Revenue from the forth quarter by -2.37% to $ 7,810.00 millions, from $ 7,999.90 millions released in the previous quarter.

But that's not big issue, as Eli Lilly And's Revenue generally tend to dip in this quarter.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Eli Lilly And's Revenue growth quarter on quarter, overall rank is 374.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #28
Overall #374
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #28
Overall #374
Revenue Q/Q Growth Statistics
High Average Low
29.6 % 1.5 % -28.64 %
 


LLY's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Eli Lilly And Company reported fall in Revenue from the previous quarter by -2.37% to $ 7,810.00 millions, from $ 7,999.90 millions achived in the previous reporting period.

But that's not important concern, as Eli Lilly And's Revenue always seem to plunge in the I. Quarter.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Eli Lilly And's Revenue growth quarter on quarter, overall rank is 374.


Eli Lilly And's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 29,322.80 $ 28,318.40 $ 27,758.50 $ 26,726.30 $ 25,485.60
Y / Y Revenue Growth (TTM) 15.06 % 15.4 % 19.58 % 16.46 % 10.39 %
Year on Year Revenue Growth Overall Ranking # 1572 # 2028 # 1462 # 1230 # 195
Seqeuential Revenue Change (TTM) 3.55 % 2.02 % 3.86 % 4.87 % 3.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 253 # 2456 # 1907 # 2016 # 261




Cumulative Revenue growth Comment
Assuming the Eli Lilly And's fiscal year would have ended in Mar 31 2022, Eli Lilly And would have reprted above average annual Revenue increase of 15.06% year on year, of $ 29,323 millions.
This marks a slow-down of the companys growth trends and from the 15.4% rise in Dec 31 2021.

In the Healthcare sector 242 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1572, from total ranking in previous quarter at 2028.

Revenue TTM Q/Q Growth Statistics
High Average Low
11.83 %
1.34 %
-4.48 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 243
Overall # 1572

Revenue TTM Y/Y Growth Statistics
High Average Low
19.58 %
4.78 %
-15.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 14
S&P 500 # 253
Cumulative Revenue growth Comment
Assuming the Eli Lilly And's fiscal year would have ended in Mar 31 2022, Eli Lilly And would have reprted above average annual Revenue increase of 15.06% year on year, of $ 29,323 millions.
This marks a slow-down of the companys growth trends and from the 15.4% rise in Dec 31 2021.

In the Healthcare sector 242 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1572, from total ranking in previous quarter at 2028.

Revenue TTM Q/Q Growth Statistics
High Average Low
11.83 %
1.34 %
-4.48 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 243
Overall # 1572

Revenue TTM Y/Y Growth Statistics
High Average Low
19.58 %
4.78 %
-15.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 14
S&P 500 # 253




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LLY's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LLY's Competitors
Revenue Growth for Eli Lilly And's Suppliers
Revenue Growth for LLY's Customers

You may also want to know
LLY's Annual Growth Rates LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roe LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Dividend Payout Ratio
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Atricure Inc 25.81%$ 25.814 millions
Biolase Inc 25.26%$ 25.259 millions
Clearpoint Neuro Inc 24.84%$ 24.839 millions
Tandem Diabetes Care Inc 24.72%$ 24.724 millions
Teladoc Health inc 24.62%$ 24.616 millions
Dexcom Inc 24.51%$ 24.515 millions
Irhythm Technologies Inc 24.31%$ 24.313 millions
Optinose Inc 23.41%$ 23.411 millions
Meiragtx Holdings Plc22.59%$ 22.590 millions
Array Technologies Inc 22.22%$ 22.223 millions
Guardant Health Inc 22.16%$ 22.162 millions
United Therapeutics Corporation21.84%$ 21.841 millions
International Stem Cell Corporation21.83%$ 21.834 millions
Vertex Pharmaceuticals Inc21.64%$ 21.643 millions
Incyte Corp21.25%$ 21.252 millions
Venus Concept Inc 20.94%$ 20.941 millions
Catalent Inc 20.86%$ 20.858 millions
Strata Skin Sciences Inc 20.83%$ 20.834 millions
Seaspine Holdings Corporation20.83%$ 20.830 millions
Exact Sciences Corporation20.64%$ 20.645 millions
Option Care Health Inc 20.62%$ 20.619 millions
Penumbra Inc20.50%$ 20.502 millions
Atrion Corporation20.35%$ 20.345 millions
Signify Health Inc 20.28%$ 20.278 millions
Apollo Endosurgery inc 20.24%$ 20.242 millions
Alnylam Pharmaceuticals Inc 20.10%$ 20.101 millions
Lifeloc Technologies Inc 19.40%$ 19.402 millions
Invitae Corporation19.37%$ 19.369 millions
Bio techne Corp19.23%$ 19.225 millions
Amicus Therapeutics inc 18.54%$ 18.543 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NOK's Profile

Stock Price

NOK's Financials

Business Description

Fundamentals

Charts & Quotes

NOK's News

Suppliers

NOK's Competitors

Customers & Markets

Economic Indicators

NOK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071